Skip to main content
OpenTrials

Clinical trial condition

Triple Negative Breast Cancer (TNBC)

Explore clinical trials studying Triple Negative Breast Cancer (TNBC). Study availability and eligibility vary by location and protocol.

50 public trials 26 recruiting studies
Refine in advanced search Browse all conditions

Triple Negative Breast Cancer (TNBC) trial results

Completed

Study of B013 and Nab-Paclitaxel for Locally Advanced or Metastatic Triple Negative Breast Cancer

NCT05555706

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations
  • Affiliated Cancer Hospital, Sun Yat-sen University Guangzhou, Guangdong, China
  • Guangxi Medical University Cancer Hospital Nanning, Guangxi, China
  • Hainan cancer Hospital Haikou, Hainan, China
  • The First Affiliated Hospital of henan University of Science and Technoloy Luoyang, Henan, China
View all 13 locations
View Trial Details
Completed

Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers

NCT02178722

Conditions
Adenocarcinoma, Adnexal Diseases, Bladder Cancer, +76 more
Locations
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • US Davis Cancer Center Sacramento, California, United States
  • University Of Colorado Cancer Center Aurora, Colorado, United States
View all 24 locations
View Trial Details
Active, Not Recruiting

Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers

NCT05891171

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Cancer, +64 more
Locations
  • Research Site Phoenix, Arizona, United States
  • Research Site Jacksonville, Florida, United States
  • Research Site Lake City, Florida, United States
  • Research Site Hinsdale, Illinois, United States
View all 14 locations
View Trial Details
Active, Not Recruiting

Onvansertib + Paclitaxel In TNBC

NCT05383196

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +15 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Beth Israel Deaconness Medical Center Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Active, Not Recruiting

OCTANE: Adjuvant Liposomal Doxorubicin and Carboplatin for Early-stage Triple-negative Breast Cancer

NCT05949021

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations
  • RWJBarnabas Health - Trinitas hospital and Comprehensive Center Elizabeth, New Jersey, United States
  • RWJBarnabas Health Jersey City Medical Center Jersey City, New Jersey, United States
  • RWJBarnabas Health - Monmouth Medical Center Southern Campus Lakewood, New Jersey, United States
  • Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
View Trial Details
Active, Not Recruiting

A Study of ADRX-0706 in Select Advanced Solid Tumors

NCT06036121

Conditions
Breast Diseases, Breast Neoplasms, Cervical Cancer, +19 more
Locations
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UCLA Los Angeles, California, United States
  • Comprehensive Hematology Oncology St. Petersburg, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View all 21 locations
View Trial Details

Related conditions